Million Veteran Program data spurs research in Diabetes, Cancer and PTSD

by Rachel Baker on September 4, 2015

A team of Vanderbilt and Nashville VA researchers have been awarded a VA grant to conduct diabetes and cancer research using the Million Veteran Program data. It will be exciting to see what innovations they can make towards the understanding and treatment of diabetes and cancer.

Read the Full article:
Million Veteran Program data spurs research in pharmacogenomics of kidney disease

Data collected from MVP will be stored anonymously for research on diseases like diabetes and cancer, and military-related illnesses such as post-traumatic stress disorder, according to the U.S. Department of Veterans Affairs.

The VA has already enrolled 390,000 veterans toward this goal, said Hung, assistant professor of Medicine in the Division of Nephrology and Hypertension, and principal investigator for the Nashville VA, which has been a top recruiter for the study.

Hung and her team will study the genetic determinants of the response to metformin for diabetes, tacrolimus-based immunotherapy for kidney transplant and the genetic determinants of hypertension.

“This will help to personalize treatment choices in the care provided to people with, or at risk for, kidney disease, and in the discovery of new targets for treatment and improved outcomes in the veteran population afflicted with these conditions,” Hung said.

This article was written by: Rachel Baker – Click to follow on Twitter; or you can follow her at The Crafty Veteran on Bloglovin. You can also follow her writing about women veteran interests at Shield Sisters

Comments on this entry are closed.

Previous post:

Next post: